accountMay 17 (Bloomberg) -- Optimer Pharmaceuticals Inc.���s Dificid is on track to lead as many as five new antibiotics onto the market over the next three years as a surge in drug- resistant germs stokes...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug-Resistant Germs Lure Biotechs to Lead Antibiotics Effort
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account